The board of Memphis Co. for Pharmaceutical & Chemical Industries endorsed financial indicators for the fiscal year that ended on June 30, 2014.
The company posted a 44% fall in full-year net profit to EGP 3.1 million, from EGP 5.5 million net profit a year earlier.
The drug manufacturer had reported EGP 1 million net loss before tax for the 11-month period from July 1, 2013 till May 31, 2014, against EGP 3.5 million net profit in the year-ago period.